Patrick Mouret

2.4k total citations · 1 hit paper
27 papers, 1.8k citations indexed

About

Patrick Mouret is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Patrick Mouret has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Internal Medicine, 17 papers in Cardiology and Cardiovascular Medicine and 12 papers in Surgery. Recurrent topics in Patrick Mouret's work include Venous Thromboembolism Diagnosis and Management (20 papers), Atrial Fibrillation Management and Outcomes (13 papers) and Acute Myocardial Infarction Research (6 papers). Patrick Mouret is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (20 papers), Atrial Fibrillation Management and Outcomes (13 papers) and Acute Myocardial Infarction Research (6 papers). Patrick Mouret collaborates with scholars based in Germany, France and United Kingdom. Patrick Mouret's co-authors include Bengt I. Eriksson, Ola E. Dahl, Ajay K. Kakkar, Sylvia Haas, Frank Misselwitz, Benjamin Brenner, A. Soglian, Ákos F. Pap, Nadia Rosencher and Alexander T. Cohen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Patrick Mouret

26 papers receiving 1.7k citations

Hit Papers

Extended duration rivaroxaban versus short-term enoxapari... 2008 2026 2014 2020 2008 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
    2008 807 citations Ajay K. Kakkar, Benjamin Brenner et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Mouret Germany 14 1.6k 1.4k 557 236 137 27 1.8k
O.E. Dahl Norway 21 2.3k 1.5× 2.2k 1.6× 806 1.4× 316 1.3× 216 1.6× 30 2.9k
Rohan Hettiarachchi Netherlands 12 2.0k 1.3× 1.9k 1.4× 630 1.1× 306 1.3× 201 1.5× 12 2.5k
Luc Sagnard France 10 1.1k 0.7× 1.3k 0.9× 746 1.3× 250 1.1× 94 0.7× 13 1.8k
Tiemo J. Bandel Germany 11 2.9k 1.8× 2.7k 1.9× 719 1.3× 323 1.4× 264 1.9× 18 3.2k
Raphael Pak Canada 10 1.7k 1.1× 1.6k 1.1× 424 0.8× 231 1.0× 74 0.5× 22 2.1k
Linda Harrison Canada 7 954 0.6× 900 0.6× 402 0.7× 241 1.0× 50 0.4× 8 1.2k
Eva Muehlhofer Germany 13 1.4k 0.9× 1.4k 1.0× 529 0.9× 159 0.7× 192 1.4× 42 1.8k
Noel Chan Canada 24 1.0k 0.7× 1.3k 0.9× 284 0.5× 263 1.1× 110 0.8× 84 1.8k
Antonio Gómez‐Outes Spain 20 738 0.5× 970 0.7× 233 0.4× 139 0.6× 130 0.9× 47 1.5k
Anita Vedel Christiansen Germany 8 1.4k 0.9× 1.4k 1.0× 419 0.8× 200 0.8× 71 0.5× 13 1.8k

Countries citing papers authored by Patrick Mouret

Since Specialization
Citations

This map shows the geographic impact of Patrick Mouret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Mouret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Mouret more than expected).

Fields of papers citing papers by Patrick Mouret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Mouret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Mouret. The network helps show where Patrick Mouret may publish in the future.

Co-authorship network of co-authors of Patrick Mouret

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Mouret. A scholar is included among the top collaborators of Patrick Mouret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Mouret. Patrick Mouret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samama, Charles Marc, Silvy Laporte, Nadia Rosencher, et al.. (2020). Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery. New England Journal of Medicine. 382(20). 1916–1925. 58 indexed citations
2.
Beyer‐Westendorf, Jan, Patrick Mouret, & Alexander G.G. Turpie. (2017). Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice. Orthopedic Research and Reviews. Volume 9. 1–11. 6 indexed citations
3.
Koscielny, Jürgen, Christian von Heymann, Rupert Bauersachs, Patrick Mouret, & Matthias Antz. (2017). Perioperative Antikoagulation mit NOAK am Beispiel Rivaroxaban. MMW - Fortschritte der Medizin. 159(S4). 18–23. 2 indexed citations
4.
Kakkar, Ajay K., Giancarlo Agnelli, Winfield S. Fisher, et al.. (2013). Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery. Annals of Surgery. 259(6). 1073–1079. 28 indexed citations
5.
Lassen, Michael R., Winfield S. Fisher, Patrick Mouret, et al.. (2012). Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE. Journal of Thrombosis and Haemostasis. 10(5). 822–832. 20 indexed citations
6.
7.
Kakkar, Ajay K., Benjamin Brenner, Ola E. Dahl, et al.. (2008). Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. The Lancet. 372(9632). 31–39. 807 indexed citations breakdown →
8.
Agnelli, Giancarlo, Bengt I. Eriksson, Alexander T. Cohen, et al.. (2008). Safety assessment of new antithrombotic agents: Lessons from the EXTEND study on ximelagatran. Thrombosis Research. 123(3). 488–497. 63 indexed citations
9.
Kakkar, Ajay K., Benjamin Brenner, Ola E. Dahl, et al.. (2007). Extended Thromboprophylaxis with Rivaroxaban Compared with Short-Term Thromboprophylaxis with Enoxaparin after Total Hip Arthroplasty: The RECORD2 Trial.. Blood. 110(11). 307–307. 13 indexed citations
10.
Dahl, Ola E., Mats Ögren, Giancarlo Agnelli, et al.. (2006). Assessment of Bleeding after Concomitant Administration of Antiplatelet and Anticoagulant Agents in Lower Limb Arthroplasty. Pathophysiology of Haemostasis and Thrombosis. 35(6). 428–434. 5 indexed citations
11.
Colwell, Clifford W. & Patrick Mouret. (2005). Ximelagatran for the Prevention of Venous Thromboembolism Following Elective Hip or Knee Replacement Surgery. Seminars in Vascular Medicine. 5(3). 266–275. 6 indexed citations
12.
Dahl, Ola E., Bengt I. Eriksson, Giancarlo Agnelli, et al.. (2005). Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery. Clinical Drug Investigation. 25(1). 65–77. 10 indexed citations
13.
Eriksson, Bengt I., Giancarlo Agnelli, Alexander T. Cohen, et al.. (2003). The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. Journal of Thrombosis and Haemostasis. 1(12). 2490–2496. 157 indexed citations
14.
Agnelli, Giancarlo, Alexander T. Cohen, Ola E. Dahl, et al.. (2003). Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. Thrombosis and Haemostasis. 89(2). 288–296. 207 indexed citations
15.
Righini, C., et al.. (2001). [Is hepatic ultrasonography necessary in the initial check-up of patients with squamous cell carcinoma of the upper respiratory and digestive tract?].. PubMed. 118(6). 359–64.
16.
Mouret, Patrick. (1999). Liposarcoma of the hypopharynx. A case report and review of the literature.. PubMed. 120(1). 39–42. 13 indexed citations
17.
Eriksson, Bengt I., Torben Jørgensen, Peter Kälebo, et al.. (1997). A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement. New England Journal of Medicine. 337(19). 1329–1335. 285 indexed citations
18.
Reyt, É., et al.. (1992). [Malignant cervical epithelial adenopathy from unknown primary source. Apropos of a series of 54 cases].. PubMed. 113(2). 95–8. 1 indexed citations
19.
Mouret, Patrick, et al.. (1991). [Lipoma of the internal auditory canal. An anatomo-clinical case study and review of the literature about cranial nerve lipomas].. PubMed. 39(4). 147–50. 3 indexed citations
20.
Comtet, J J, P Willems, & Patrick Mouret. (1979). Ring injury with bilateral rupture of the digital arteries without skin damage. The Journal Of Hand Surgery. 4(5). 415–416. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O.E. Dahl Breakdown of academic impact, for papers by Rohan Hettiarachchi Breakdown of academic impact, for papers by Luc Sagnard Breakdown of academic impact, for papers by Tiemo J. Bandel Breakdown of academic impact, for papers by Raphael Pak Breakdown of academic impact, for papers by Linda Harrison Breakdown of academic impact, for papers by Eva Muehlhofer Breakdown of academic impact, for papers by Noel Chan Breakdown of academic impact, for papers by Antonio Gómez‐Outes Breakdown of academic impact, for papers by Anita Vedel Christiansen
Rankless by CCL
2026